Tolazoline HClCAS# 59-97-2 |
- AZD3514
Catalog No.:BCC1070
CAS No.:1240299-33-5
- 17 alpha-propionate
Catalog No.:BCC1296
CAS No.:19608-29-8
- Andarine
Catalog No.:BCC1168
CAS No.:401900-40-1
- MDV3100 (Enzalutamide)
Catalog No.:BCC1268
CAS No.:915087-33-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 59-97-2 | SDF | Download SDF |
PubChem ID | 6048 | Appearance | Powder |
Formula | C10H13ClN2 | M.Wt | 196.68 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | H2O : ≥ 50 mg/mL (254.22 mM) DMSO : 33.33 mg/mL (169.46 mM; Need ultrasonic) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | 2-benzyl-4,5-dihydro-1H-imidazole;hydrochloride | ||
SMILES | C1CN=C(N1)CC2=CC=CC=C2.Cl | ||
Standard InChIKey | RHTNTTODYGNRSP-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C10H12N2.ClH/c1-2-4-9(5-3-1)8-10-11-6-7-12-10;/h1-5H,6-8H2,(H,11,12);1H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Tolazoline HCl Dilution Calculator
Tolazoline HCl Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.0844 mL | 25.422 mL | 50.844 mL | 101.688 mL | 127.11 mL |
5 mM | 1.0169 mL | 5.0844 mL | 10.1688 mL | 20.3376 mL | 25.422 mL |
10 mM | 0.5084 mL | 2.5422 mL | 5.0844 mL | 10.1688 mL | 12.711 mL |
50 mM | 0.1017 mL | 0.5084 mL | 1.0169 mL | 2.0338 mL | 2.5422 mL |
100 mM | 0.0508 mL | 0.2542 mL | 0.5084 mL | 1.0169 mL | 1.2711 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Tolazoline is a non-selective competitive α-adrenergic receptor antagonist.
- Levodopa
Catalog No.:BCN1098
CAS No.:59-92-7
- Nitrofurazone
Catalog No.:BCC3825
CAS No.:59-87-0
- Nicotinic acid
Catalog No.:BCN8328
CAS No.:59-67-6
- DL-Methionine
Catalog No.:BCC8318
CAS No.:59-51-8
- Oxindole
Catalog No.:BCN4050
CAS No.:59-48-3
- Procaine
Catalog No.:BCC5210
CAS No.:59-46-1
- Thiamine chloride
Catalog No.:BCN8344
CAS No.:59-43-8
- Sulfaquinoxaline
Catalog No.:BCC9158
CAS No.:59-40-5
- Mepyramine maleate
Catalog No.:BCC6740
CAS No.:59-33-6
- Folic acid
Catalog No.:BCN5375
CAS No.:59-30-3
- D-Galactose
Catalog No.:BCN8528
CAS No.:59-23-4
- 5-BrdU
Catalog No.:BCC5293
CAS No.:59-14-3
- Betaine hydrochloride
Catalog No.:BCN6304
CAS No.:590-46-5
- Bethanechol chloride
Catalog No.:BCC4566
CAS No.:590-63-6
- alpha-Endorphin
Catalog No.:BCC1010
CAS No.:59004-96-5
- 8-Hydroxyhyperforin 8,1-hemiacetal
Catalog No.:BCN4091
CAS No.:59014-02-7
- Atropine sulfate monohydrate
Catalog No.:BCC3728
CAS No.:5908-99-6
- Dehydrotoxicarol
Catalog No.:BCN3991
CAS No.:59086-93-0
- Albaspidin AP
Catalog No.:BCN2398
CAS No.:59092-91-0
- (+)-Rhododendrol
Catalog No.:BCN7091
CAS No.:59092-94-3
- Alpha-Angelica lactone
Catalog No.:BCN5001
CAS No.:591-12-8
- Misoprostol
Catalog No.:BCC5240
CAS No.:59122-46-2
- Neoisoliquiritin
Catalog No.:BCN2936
CAS No.:59122-93-9
- PSB 10 hydrochloride
Catalog No.:BCC7238
CAS No.:591771-91-4
[Tolazoline-HCl in cardio-respiratory adaptation of newborns with respiratory distress syndrome (author's transl)].[Pubmed:7335091]
Monatsschr Kinderheilkd. 1981 Oct;129(10):571-4.
The pharmacological effects of Tolazoline were studied in newborns with different types of pulmonary diseases. The drug was given when the arterial pO2 remained below 6,65 kP in spite of PEEP, and when the right-to-left shunt was greater than 60%. Continuous monitoring of arterial blood pressure and pO2 were of particular importance. Permanent improvement was found in 50%. Transitional improvement in 30% of the cases and in the remaining 20% the drug had no observable effect.